Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba for Cognitive Impairment in MS
NCT00841321Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Jan 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing Ginkgo biloba with Placebo (2 arms). Primary endpoints: Performance on the Interference Condition of the Stroop Test at 12 weeks, Performance on the Long Delay Free Recall Portion of the California Verbal Learning Test II at 12 weeks and 2 more. Started Jan 2009; status: completed.
02
Drugs
Vasoclean
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00841321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841321.